CYTOR and hepatocellular carcinoma: Co-transfection of CYTOR with miR-125a-5p inhibitor reversed the effect of sh-miR-125a-5p on apoptosis, proliferation, tumor volume and weight, suggesting that CYTOR promotes HCC growth by modulating miR-125a-5p.